MA38368B1 - Oral Formulations of Deferasirox - Google Patents

Oral Formulations of Deferasirox

Info

Publication number
MA38368B1
MA38368B1 MA38368A MA38368A MA38368B1 MA 38368 B1 MA38368 B1 MA 38368B1 MA 38368 A MA38368 A MA 38368A MA 38368 A MA38368 A MA 38368A MA 38368 B1 MA38368 B1 MA 38368B1
Authority
MA
Morocco
Prior art keywords
deferasirox
oral formulations
neutral
formulations
release
Prior art date
Application number
MA38368A
Other languages
French (fr)
Other versions
MA38368A1 (en
Inventor
Indrajit Ghosh
Jia-Ai Zhang
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from PCT/IB2014/059494 external-priority patent/WO2014136079A1/en
Publication of MA38368A1 publication Critical patent/MA38368A1/en
Publication of MA38368B1 publication Critical patent/MA38368B1/en

Links

Abstract

L'invention concerne des formulations de déféraxirox administrables par voie orale, présentant une libération réduite dans des conditiosn grastriques et une libération rapide à un ph presque neutre ou à un ph neutre.The invention relates to orally administrable deferaxirox formulations having reduced release in gastric conditions and rapid release to near neutral pH or neutral pH.

MA38368A 2013-03-08 2014-03-06 Oral Formulations of Deferasirox MA38368B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361774893P 2013-03-08 2013-03-08
PCT/IB2014/059494 WO2014136079A1 (en) 2013-03-08 2014-03-06 Oral formulations of deferasirox

Publications (2)

Publication Number Publication Date
MA38368A1 MA38368A1 (en) 2017-03-31
MA38368B1 true MA38368B1 (en) 2018-10-31

Family

ID=56119072

Family Applications (1)

Application Number Title Priority Date Filing Date
MA38368A MA38368B1 (en) 2013-03-08 2014-03-06 Oral Formulations of Deferasirox

Country Status (2)

Country Link
AR (1) AR095058A1 (en)
MA (1) MA38368B1 (en)

Also Published As

Publication number Publication date
MA38368A1 (en) 2017-03-31
AR095058A1 (en) 2015-09-16

Similar Documents

Publication Publication Date Title
BR112015021254A2 (en) oral formulations of deferasirox
EA201990615A1 (en) Pyrrolobenzodiazepine conjugates
MA44890B1 (en) Compositions comprising bacterial strains
MA39095A1 (en) Anti-cd33 antibodies and immunoconjugates
MA37538A2 (en) Anti-Ly6 antibodies and immunoconjugates and methods of use
MA38686A1 (en) Teichoic acid antibodies to the cell wall and associated conjugates
MA47664B1 (en) Anti-c10orf54 Antibodies and Their Uses
MA44637B1 (en) Heterocyclic compounds and their uses
FR2995679B1 (en) TORQUE SENSOR AND ASSISTED STEERING SYSTEM USING THE SAME
IT201700070755A1 (en) "SEPARATION SYSTEM"
MA44550A1 (en) Cell wall teichoic acid antibodies and conjugated conjugates
DK3244878T3 (en) Solid oral formulations
MA41159A (en) OCTREOTIDE FOR ORAL ADMINISTRATION IN ASSOCIATION WITH OTHER THERAPEUTIC AGENTS
MA52021A (en) ANTI-LIF ANTIBODIES AND THEIR GALENIC FORMS
FR3058067B1 (en) CIRCULATORY ASSISTANCE SYSTEM
MA38368B1 (en) Oral Formulations of Deferasirox
MA39336A1 (en) Anti-lag-3 antibody molecules and their uses
ITUA20163609A1 (en) "MICRO-COGENERATOR".
FR3039495B1 (en) CYCLE CHAIN DRIVE ASSISTANCE KIT AND CIRCUIT CYCLE
ES1218814Y (en) INTIMATE MALE PROTECTION CLOTHING FOR SEXUAL PRACTICES.
IT201700030430A1 (en) ANTI-SEISMIC CONSTRUCTION SYSTEM CALLED "ANTI-SEISMIC HYBRID"
CN302362742S (en) Quick Drain Screw Valve (2)
MA39300A1 (en) Anti-IL-13 / IL-17 Bispecific Antibodies and Their Uses
ITUB20152752A1 (en) UNIVERSAL MECHANICAL-MAGNETIC CONNECTOR THAT ALLOWS THE CONNECTION BETWEEN THE SAME OR DIFFERENT PARTS BETWEEN THEM WITHOUT THE USE OF SCREWS AND BOLTS.
MA46980B1 (en) Compositions comprising bacterial strains